Common brain cancer mutation changes DNA shape to drive progression, exposing therapeutic target

Researchers at MD Anderson Cancer Center have discovered that ATRX gene mutations rewire the 3D structure of DNA in glioma cells to promote tumor growth. This finding identifies potential new therapeutic targets, specifically within the HOXA gene family, to slow cancer progression.
Why it matters
Understanding the epigenetic mechanisms of glioma could lead to more effective, personalized treatments for a common and aggressive form of brain cancer.
by University of Texas MD Anderson Cancer Center
The report is a straightforward summary of scientific research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in